Enovis

ENOV

Market cap $1.46B

Enovis Corporation (ENOV) Q4 2025 Earnings Call Transcript

Front Street added 156,069 shares of Enovis in the fourth quarter. The quarter-end position value increased by $3.40 million, reflecting both trading activity and share price changes.

Enovis (ENOV) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.98 per share a year ago.

Dallas, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and full year ended December 31, 2025. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.

Dallas, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and full year ended December 31, 2025. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.

Enovis continues to struggle in the market, as institutional investors just aren't interested in mid-single-digit growth from a mid-cap name. Management has guided for up to low-double-digit Recon growth in 2026, but overall growth, margin leverage, and meaningful free cash flow generation remain key hurdles for rerating. Bringing successful products over from Europe could drive more growth in hips and shoulders, but it will take time and clinical trials to get them to the market.

Dallas TX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 11, 2026 in Snowbird, UT. About Enovis Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life.

Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2025 financial results on Thursday, February 26th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Enovis Corporation (ENOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript